GlassScriptPhysician profile
Eugene Ritter Sansoni
NPI 1508158965
$7,515.25
in general payments reported to CMS, 2019-2025
11 companies · $1,808 in 2025
The $1,808 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $184 · 2021: $80.05 · 2022: $211 · 2023: $3,787 · 2024: $1,138 · 2025: $1,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,213 · Food and Beverage: $1,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,213.05 |
| Food and Beverage | $1,519.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,551.53 | 2021-2024 | Nuvent, Propel, Pteye Parathyroid Detection System |
| Stryker Corporation | $2,150.81 | 2019-2025 | Scopis Ent, Cmi, Alphavent |
| Inspire Medical Systems, INC. | $1,183.01 | 2023-2024 | Inspire |
| Medtronic USA, INC. | $209.81 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $121.87 | 2023 | Libtayo |
| Glaxosmithkline, LLC. | $119.93 | 2023-2024 | Nucala |
| Ethicon US, LLC | $79.58 | 2019-2024 | Vistaseal, Stratafix |
| Smith+Nephew, INC. | $34.39 | 2020-2025 | Stravix |
| Pentax of America, INC. | $34.09 | 2022 | |
| Karl Storz Endoscopy-America | $16.71 | 2020 | |
| Tactile Systems Technology INC | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Sansoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.